The World's First Drug To Treat Neointimal Disease
Vasocure is a clinical-stage nephrology therapeutics company with the world's first peptide to directly treat neointimal hyperplasia, or neointimal disease, arteriosclerosis, and atherosclerosis. Learn more at vasocuretherapeutics.com.
As their creative partner, we provided:
Behind the scenes
Video shoot and photography session at our New York City office.